Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Compr Psychiatry ; 51(6): 599-602, 2010.
Article in English | MEDLINE | ID: mdl-20965306

ABSTRACT

OBJECTIVE: To investigate the prevalence of psychiatric disorders among women in ambulatory treatment for polycystic ovary syndrome (PCOS) and to correlate its clinical and demographic aspects with mental disorders. METHODOLOGY: Seventy-two patients in ambulatory treatment at the Endocrinal and Gynaecological Institute of the Federal University of Rio de Janeiro were evaluated using Diagnostic and Statistical Manual for Mental Disorders, Fourth Edition criteria by means of MINI (Mini International Neuropsychiatric Interview, version 4.4). Polycystic ovary syndrome was confirmed according to the ultrasonographic criteria of Adams and by clinical parameters. RESULTS: Forty-one patients (57%) presented at least one psychiatric diagnosis. Among them, the prevalence of mood disorder reached 78%. The most prevalent diagnostics were major depression (26.4%) and bipolar disorder (11.1%). CONCLUSION: A high prevalence of mental disorders was observed, especially major depression and bipolar disorder. The data obtained regarding the relationship between PCOS and mood disorders in a Brazilian sample is in accordance with recent research findings in the same area.


Subject(s)
Mental Disorders/epidemiology , Polycystic Ovary Syndrome/epidemiology , Adult , Anxiety Disorders/epidemiology , Bipolar Disorder/epidemiology , Brazil , Comorbidity , Cross-Sectional Studies , Depressive Disorder, Major/epidemiology , Diagnostic and Statistical Manual of Mental Disorders , Dysthymic Disorder/epidemiology , Female , Humans , Interview, Psychological , Phobic Disorders/epidemiology , Young Adult
2.
Psychiatry Res ; 175(3): 260-5, 2010 Feb 28.
Article in English | MEDLINE | ID: mdl-20036427

ABSTRACT

Our objective was to explore the dose-response relationship in patients with panic disorder and social anxiety disorder comorbidity (DSM-IV). After 1 week of no-drug washout, 36 such patients were assigned to a double-blind controlled comparison of the effects of 30 mg and 60 mg of tranylcypromine, and were followed up for 12 weeks. The main instrument used to measure the number of panic attacks was the Sheehan Panic and Anticipatory Anxiety Scale. The primary outcome measure for social anxiety disorder symptoms was the mean change from baseline in the Liebowitz Social Anxiety Scale (LSAS). After 12 weeks of treatment, panic attacks were reduced 69.6% from baseline in the 30-mg group (n=19) compared with a 74.8% reduction in the 60-mg group (n=17). Twelve patients (70.6%) of the higher dose group and 14 patients (68.4%) of the lower dose were completely free of panic attacks. There was no difference in efficacy between the tranylcypromine groups in the panic disorder symptoms. The 60-mg dose was more efficacious as measured by the LSAS scores, showing a significant difference in relation to the lower group. Mean change from baseline in LSAS total score (mean+/-SD) for 30-mg group was 17.9+/-14.7 and for the 60-mg group was 35.0+/-14.8. The social anxiety symptom scale showed a two-fold greater change with the 60-mg dose, and the 30-mg dose group could be considered the equivalent of a placebo control group. Tranylcypromine--60 mg daily--was found effective in the treatment of panic disorder and social anxiety disorder comorbidity.


Subject(s)
Monoamine Oxidase Inhibitors/therapeutic use , Panic Disorder/drug therapy , Phobic Disorders/drug therapy , Tranylcypromine/therapeutic use , Adult , Analysis of Variance , Dose-Response Relationship, Drug , Double-Blind Method , Female , Humans , Male , Middle Aged , Panic Disorder/complications , Phobic Disorders/complications , Psychiatric Status Rating Scales , Severity of Illness Index
3.
Psychiatry Res ; 169(2): 149-53, 2009 Sep 30.
Article in English | MEDLINE | ID: mdl-19698996

ABSTRACT

Studies have demonstrated the vulnerability of anxiety disorder patients to challenge tests. Our aim was to observe if panic disorder (PD) patients and generalized social anxiety disorder (GSAD) and performance social anxiety disorder (PSAD) patients respond in a similar way to the induction of anxiety symptoms and panic attacks by an oral caffeine challenge test. We compared 28 PD patients, 25 GSAD patients, 19 PSAD, and 26 control subjects after a 480-mg caffeine test. The patients had not received psychotropic drugs for at least a 4-week period. In a randomized double-blind experiment performed in two occasions 7 days apart, 480 mg of caffeine and a caffeine-free solution were administered and anxiety scales were administered before and after each test. A panic attack was induced in 17 (60.7%) PD patients, 4 (16.0%) GSAD patients, and 10 (52.6%) PSAD patients, during the caffeine test. None of the control subjects had a panic attack after the caffeine intake. Neither patients nor any control subject had a panic attack after drinking the caffeine-free solution. Our data suggest that there is an association between PD and PSAD hyperreactivity to an oral caffeine challenge test. The PD and PSAD patients had a higher number of induced panic attacks, some specific anxiety symptoms, and a more severe anxiety response than GSAD patients and normal volunteers.


Subject(s)
Caffeine , Central Nervous System Stimulants , Panic Disorder/chemically induced , Panic Disorder/diagnosis , Phobic Disorders/chemically induced , Phobic Disorders/diagnosis , Adolescent , Adult , Analysis of Variance , Caffeine/adverse effects , Central Nervous System Stimulants/adverse effects , Double-Blind Method , Humans , Middle Aged , Psychiatric Status Rating Scales , Social Behavior , Surveys and Questionnaires , Young Adult
4.
J Affect Disord ; 106(1-2): 185-9, 2008 Feb.
Article in English | MEDLINE | ID: mdl-17604118

ABSTRACT

BACKGROUND: Mood disorders are considered related to anxiety disorders and their association may determine clinical course and prognosis. We aimed to describe with retrospective methodology the demographic, clinical, and treatment features in a group of panic disorder comorbid with bipolar I disorder (PD-BI) patients who were been treated for at least 3 year-period and compare them with bipolar I (BI) patients who were treated during the same period. METHOD: We compared the demographic and clinical data of 26 PD-BI, 28 BI, and 25 panic disorder (PD) outpatients without history of comorbidity with mood disorder were diagnosed and treated for at least 3 years in the Federal University of Rio de Janeiro. RESULTS: PD group have a higher educational level, are more married, and are more economically active. In the PD-BI and BI patients the disorders started earlier. They also turn out to have an equivalent pattern in the presence of drug abuse episodes, moderate or severe depressive episodes, psychotic episodes, suicide attempts, maniac episodes, mixed episodes, use of fewer days of antidepressants and benzodiazepines, and use of more days of antipsychotics and mood stabilizers. The PD-BI and the BI groups had a higher frequency of depressive episodes and psychotic episodes. LIMITATIONS: It is a retrospective data description based on a naturalistic treatment. The sample has a small size and the some data could be different in a large sample. CONCLUSION: PD-BI patients have demographic, clinical and therapeutic features similar to BI and the data support its validation as a special severe bipolar I disorder subgroup.


Subject(s)
Bipolar Disorder/epidemiology , Panic Disorder/epidemiology , Adolescent , Adult , Anticonvulsants/therapeutic use , Antidepressive Agents/therapeutic use , Antipsychotic Agents/therapeutic use , Benzodiazepines/therapeutic use , Bipolar Disorder/diagnosis , Bipolar Disorder/drug therapy , Brazil , Comorbidity , Female , Humans , Male , Middle Aged , Panic Disorder/diagnosis , Panic Disorder/drug therapy , Retrospective Studies , Socioeconomic Factors
5.
Depress Anxiety ; 25(10): 847-53, 2008.
Article in English | MEDLINE | ID: mdl-17823963

ABSTRACT

Our aim was to observe the induction of anxiety symptoms and panic attacks by a caffeine challenge test in panic disorder (PD) patients (DSM-IV) and their healthy first-degree relatives. We randomly selected 25 PD patients, 27 healthy first-degree relatives of probands with PD, and 22 healthy volunteers with no family history of PD. In a randomized double-blind experiment performed over two occasions 7 days apart, 480 mg caffeine and a caffeine-free solution were administered in a coffee form. Using specific panic attack criteria, 52.0% (n=13) PD patients, 40.7% (n=11) first-degree relatives (chi2=1.81, df=1, P=0.179), and none of the control subjects had a panic attack after the test (chi2=51.7, df=2, P<0.001). In this caffeine challenge test, PD patients and their first-degree relatives were more sensitive than healthy volunteers to the panic attack symptoms but less sensitive to headache, increase in blood pressure, and insomnia. Our data suggest that there is an association between panic attacks after the intake of 480 mg of caffeine in PD patients and their first-degree relatives. There is a clear differentiation of PD patients and their first-degree relatives by a caffeine test from the healthy group.


Subject(s)
Caffeine , Central Nervous System Stimulants , Citrates , Panic Disorder/genetics , Adult , Arousal/drug effects , Arousal/genetics , Double-Blind Method , Female , Genetic Predisposition to Disease/genetics , Genetic Predisposition to Disease/psychology , Humans , Male , Middle Aged , Panic Disorder/diagnosis , Panic Disorder/psychology , Personality Inventory , Phenotype , Young Adult
6.
Rev. psiquiatr. Rio Gd. Sul ; 29(3): 315-320, set.-dez. 2007. tab
Article in English, Portuguese | LILACS-Express | LILACS | ID: lil-480159

ABSTRACT

OBJETIVO: Determinar, pela primeira vez, em uma amostra ambulatorial brasileira, o impacto dos diagnósticos psiquiátricos sobre os sintomas da menopausa presentes no índice de menopausa de Blatt-Kupperman (B-K). MÉTODOS: Avaliamos consecutivamente, através do instrumento diagnóstico estruturado MINI 4.4 e da entrevista psiquiátrica tradicional, mulheres (n = 86) em atendimento no ambulatório de menopausa do Instituto de Ginecologia da Universidade Federal do Rio de Janeiro. As pacientes incluídas no estudo (n = 48) foram avaliadas pela escala B-K até 6 meses antes ou depois da entrevista pelo MINI e divididas em dois grupos: o grupo com algum transtorno depressivo-ansioso (GTDA) (n = 26) e o grupo-controle (GC) (n = 22). RESULTADOS: O GTDA apresentou uma pontuação significativamente maior do que o GC na escala de B-K (22,6 versus 13,7). Entre os sintomas significativamente mais intensos no GTDA estão parestesia e melancolia. Além disso, observamos que as pacientes do GTDA queixavam-se de um maior número de sintomas do que as pacientes do GC (6,8 vs. 4,8). Entre os sintomas significativamente mais relatados no GTDA, estão parestesia, fraqueza e melancolia. CONCLUSÃO: Apesar da limitação da pequena amostra, pudemos observar o significativo viés dos transtornos depressivos e ansiosos sobre as pacientes em tratamento por queixas referentes à menopausa. Por esse motivo, o perfil sintomático de cada paciente deve ser sempre observado, evitando o ginecologista basear-se na intensidade global dos sintomas do B-K para decidir sobre o tratamento.


OBJECTIVE: To establish for the first time in a Brazilian outpatient sample the impact of depressive and anxiety disorders over the symptoms of the Blatt-Kupperman menopausal index (B-K). METHODS: Women (n = 86) receiving care in the menopause clinic at Instituto de Ginecologia da Universidade Federal do Rio de Janeiro were consecutively assessed using a structured diagnostic instrument (MINI 4.4) and a traditional psychiatric interview. Patients included in the study (n = 48) were assessed using the B-K scale within 6 months before or after the MINI. The total sample was divided into the anxiety and depressive disorder group (GTDA) (n = 26) and the control group (CG) (n = 22). RESULTS: B-K total scores were greater in the GTDA comparing with the CG (22.6 vs. 13.7). Paresthesia and melancholia were significantly more severe in the GTDA. GTDA patients also complained of a greater number of symptoms (6.8 vs. 4.8) than the GC. Paresthesia, weakness and melancholia were significantly more present in the GTDA. CONCLUSION: Although the small sample limitation we could observe a great bias of depressive and anxiety disorders over menopause outpatients. For that reason, the symptomatic profile of each patient must always be observed by the gynecologist, avoiding exclusive observation of B-K total score to decide about the treatment.

7.
Arch. Clin. Psychiatry (Impr.) ; 34(5): 243-245, 2007.
Article in Portuguese | LILACS | ID: lil-470340

ABSTRACT

CONTEXTO: A relevância da descrição deste caso clínico é demonstrar a importância do uso de nortriptilina em um caso de depressão maior pós-tratamento para endometriose. OBJETIVO: Demonstrar as relações entre o tratamento para endometriose e os transtornos psiquiátricos e o resultado terapêutico que obtivemos com o uso da nortriptilina. MÉTODOS: Entrevista psiquiátrica e avaliação clínica psiquiátrica periódica de uma paciente em tratamento no ambulatório do Instituto de Psiquiatria da Universidade Federal do Rio de Janeiro. RESULTADOS: Mulher de 25 anos que, após início de supressão hormonal com goserelina para o tratamento da endometriose, passou a apresentar sintomatologia depressiva e ansiosa proeminente. Sem melhora com o uso de 20 mg/dia de fluoxetina por 8 semanas, foram prescritos 25 mg/dia de nortriptilina com boa resposta clínica em 2 semanas, mantendo a melhora depois de 16 semanas. CONCLUSÃO: Apesar de apenas a sertralina ter sua eficácia demonstrada na melhora dos sintomas depressivos associados à supressão ovariana, neste caso a nortriptilina demonstrou-se eficaz. Observamos a necessidade de estudos crescentes na área a fim de avaliar outras opções terapêuticas.


BACKGROUND: The relevance of this clinical case report is to emphasize the importance of the use of nortryptiline for major depression after endometriosis treatment. OBJECTIVE: To describe by a case report the relationship between treatment for endometriosis and psychiatric disorders. We will also describe the therapeutic response to nortriptyline. METHODS: Psychiatric interview and periodical clinical psychiatric evaluation for the treatment of a patient in the Outpatient Unit of the Institute of Psychiatry of the Federal University of Rio de Janeiro. RESULTS: An outpatient, fifty-five year-old woman with major depression treated in the Psychiatric Institute of Federal University of Rio de Janeiro. She was being treated for endometriosis with goserelin for hormone suppression when she started to complain of depressive and anxiety symptoms. The patient did not improve with 20 mg/day of fluoxetine for 8 weeks. She improved after 2 weeks using 25 mg/day of nortryptiline. The improvement persisted during our 16 weeks follow-up. CONCLUSION: Although only sertraline has its efficacy demonstrated for depressive symptoms associated with ovarian suppression, in this case nortriptyline was efficient too. We observed the necessity of more studies about this topic in order to better evaluate other therapeutic options.


Subject(s)
Humans , Female , Adult , Endometriosis/therapy , Nortriptyline/therapeutic use , Anxiety/therapy , Depression/therapy , Endometrium
8.
Rev. psiquiatr. Rio Gd. Sul ; 28(2): 130-134, maio-ago. 2006. tab
Article in Portuguese | LILACS-Express | LILACS | ID: lil-445842

ABSTRACT

OBJETIVO: Determinar a prevalência dos transtornos depressivo-ansiosos entre mulheres atendidas em um ambulatório de menopausa. METODOLOGIA: Avaliamos, através da entrevista semi-estruturada Mini International Neuropsychiatric Interview, 86 mulheres que encontravam-se em tratamento no ambulatório de menopausa do Instituto de Ginecologia da Universidade Federal do Rio de Janeiro. RESULTADOS: A maioria das mulheres apresentava algum diagnóstico psiquiátrico (57 por cento) sendo mais prevalentes o transtorno de ansiedade generalizada (34,9 por cento) e a depressão maior (31,4 por cento). O grupo com algum diagnóstico foi representado por mulheres mais jovens, casadas, com menor escolaridade e história familiar para transtornos psiquiátricos. CONCLUSÃO: Observamos uma grande prevalência de transtornos mentais entre mulheres em atendimento ambulatorial na menopausa em nosso estudo, em relação às mulheres em atendimento em outros ambulatórios segundo a literatura. Há também uma alta taxa de prevalência de comorbidades (55,5 por cento dos pacientes com algum transtorno) complicadoras do transtorno primário, o que pode representar a evolução para pior prognóstico pela ausência de tratamento precoce e específico.


OBJETIVE: To determine the prevalence of depressive and anxiety disorders in women receiving care in a menopause clinic. METHODS: Eighty-six women receiving care in the menopause clinic at Instituto de Ginecologia da Universidade Federal do Rio de Janeiro were assessed using the Mini-International Neuropsychiatric Interview. RESULTS: Most women had a psychiatric diagnosis (57 percent); generalized anxiety disorder (34.9 percent) and major depression (31.4 percent) were the most prevalent disorders. The group composed of subjects with any disorder was represented by young and married women, with lower schooling level and family history for psychiatric disorders. CONCLUSION: In our study, there was a high prevalence of psychiatric disorders in outpatient women receiving care in a menopause clinic, in relation to women receiving care in other outpatient clinics, as described in the literature. There was also a high prevalence of comorbid diseases (55.5 percent of patients with any disorder) complicating the primary disorder, which may compromise the prognosis due to lack of early specific treatment.

SELECTION OF CITATIONS
SEARCH DETAIL
...